Genetic, cellular and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

  1. Evgeniya Trofimenko
  2. Gianvito Grasso
  3. Mathieu Heulot
  4. Nadja Chevalier
  5. Marco A Deriu
  6. Gilles Dubuis
  7. Yoan Arribat
  8. Marc Serulla
  9. Sebastien Michel
  10. Gil Vantomme
  11. Florine Ory
  12. Lihn Chi Dam
  13. Julien Puyal
  14. Francesca Amati
  15. Anita Lüthi
  16. Andrea Danani
  17. Christian Widmann  Is a corresponding author
  1. University of Lausanne, Switzerland
  2. Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, Switzerland
  3. Politecnico di Torino, Italy
  4. Université de Lausanne, Switzerland

Abstract

Cell-penetrating peptides (CPPs) allow intracellular delivery of bioactive cargo molecules. The mechanisms allowing CPPs to enter cells are ill-defined. Using a CRISPR/Cas9-based screening, we discovered that KCNQ5, KCNN4, and KCNK5 potassium channels positively modulate cationic CPP direct translocation into cells by decreasing the transmembrane potential (Vm). These findings provide the first unbiased genetic validation of the role of Vm in CPP translocation in cells. In silico modeling and live cell experiments indicate that CPPs, by bringing positive charges on the outer surface of the plasma membrane, decrease the Vm to very low values (-150 mV or less), a situation we have coined megapolarization that then triggers formation of water pores used by CPPs to enter cells. Megapolarization lowers the free energy barrier associated with CPP membrane translocation. Using dyes of varying dimensions in CPP co-entry experiments, the diameter of the water pores in living cells was estimated to be 2(-5) nm, in accordance with the structural characteristics of the pores predicted by in silico modeling. Pharmacological manipulation to lower transmembrane potential boosted CPPs cellular internalization in zebrafish and mouse models. Besides identifying the first proteins that regulate CPP translocation, this work characterized key mechanistic steps used by CPPs to cross cellular membrane. This opens the ground for strategies aimed at improving the ability of cells to capture CPP-linked cargos in vitro and in vivo.

Data availability

DNA sequencing data from the CRISPR/Cas9-based screens are available through the following link: https://www.ncbi.nlm.nih.gov/sra/SRP161445.

The following data sets were generated

Article and author information

Author details

  1. Evgeniya Trofimenko

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4910-5324
  2. Gianvito Grasso

    Dalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, Ticino, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Mathieu Heulot

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Nadja Chevalier

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Marco A Deriu

    Bioingegneria Industriale, Politecnico di Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Gilles Dubuis

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  7. Yoan Arribat

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0952-5279
  8. Marc Serulla

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4166-1556
  9. Sebastien Michel

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  10. Gil Vantomme

    Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7441-0737
  11. Florine Ory

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  12. Lihn Chi Dam

    Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  13. Julien Puyal

    Department of Fundamental Neurology, Université de Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Francesca Amati

    Department of Physiology, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  15. Anita Lüthi

    Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4954-4143
  16. Andrea Danani

    Dalle Molle Institute for Artificial Intelligence Research, Università della Svizzera italiana, Scuola Universitaria Professionale della Svizzera Italiana, Ticino, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  17. Christian Widmann

    Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
    For correspondence
    Christian.Widmann@unil.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6881-0363

Funding

Swiss National Science Foundation (CRSII3_154420,IZCSZ0-174639)

  • Christian Widmann

Swiss National Science Foundation (158116)

  • Nadja Chevalier

Swiss National Science Foundation (320030_170062)

  • Francesca Amati

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Patricia Bassereau, Institut Curie, France

Ethics

Animal experimentation: All experiments were performed according to the principles of laboratory animal care and Swiss legislation under ethical approval (Swiss Animal Protection Ordinance; permit number VD3374.a).

Version history

  1. Preprint posted: February 26, 2020 (view preprint)
  2. Received: April 27, 2021
  3. Accepted: October 28, 2021
  4. Accepted Manuscript published: October 29, 2021 (version 1)
  5. Version of Record published: December 2, 2021 (version 2)

Copyright

© 2021, Trofimenko et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,848
    views
  • 617
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Evgeniya Trofimenko
  2. Gianvito Grasso
  3. Mathieu Heulot
  4. Nadja Chevalier
  5. Marco A Deriu
  6. Gilles Dubuis
  7. Yoan Arribat
  8. Marc Serulla
  9. Sebastien Michel
  10. Gil Vantomme
  11. Florine Ory
  12. Lihn Chi Dam
  13. Julien Puyal
  14. Francesca Amati
  15. Anita Lüthi
  16. Andrea Danani
  17. Christian Widmann
(2021)
Genetic, cellular and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore
eLife 10:e69832.
https://doi.org/10.7554/eLife.69832

Share this article

https://doi.org/10.7554/eLife.69832

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.

    1. Cell Biology
    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.